newsfilter
← Latest News
PR Newswire·

Tryp Therapeutics Appoints New Chief Operating Officer

Sid Taubenfeld with Extensive Experience in the Financial Markets and as a Biotech Executive Joins Tryp as Company Prepares to Expand Patient Access to Psilocybin-Based Treatments SAN DIEGO, June 23, 2022 /PRNewswire/ -- Tryp Therapeutics, Inc. (CSE:T